Ready to play
Ready to play
Egypt has announced the successful localization of the production of nine medicinal preparations for treating cancer patients and blood disorders. These are being produced domestically for the first time and target the treatment of liver, breast, and lung cancers, as well as leukemia and immune thrombocytopenia. This achievement aims to strengthen pharmaceutical security, reduce dependence on imports, and ensure the availability of high-quality medicines in a sustainable manner, making them accessible to Egyptian patients at affordable prices. Additionally, this localization effort supports national programs for early cancer detection, reduces costs, and enhances the manufacturing capacity of medicines. It is also expected to add 12 new therapeutic substances by 2029, with the goal of protecting patients' health and advancing the local pharmaceutical industry.
Notice: This Is an AI-Generated Summary
Comments (0)